Novo Nordisk
NVO
#35
Rank
A$440.45 B
Marketcap
$97.86
Share price
2.17%
Change (1 day)
-49.60%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$70.26 Billion

According to Novo Nordisk's latest financial reports the company's total liabilities are A$70.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novo Nordisk - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$72.30 B59.97%
2023-12-31A$45.19 B35.38%
2022-12-31A$33.38 B28.46%
2021-12-31A$25.99 B48.17%
2020-12-31A$17.54 B20.42%
2019-12-31A$14.56 B13.65%
2018-12-31A$12.81 B18.13%
2017-12-31A$10.84 B5.67%
2016-12-31A$10.26 B13.85%
2015-12-31A$9.01 B22.9%
2014-12-31A$7.33 B27.31%
2013-12-31A$5.76 B34.92%
2012-12-31A$4.27 B-7.73%
2011-12-31A$4.62 B7.84%
2010-12-31A$4.29 B5.33%
2009-12-31A$4.07 B-13.32%
2008-12-31A$4.70 B34.91%
2007-12-31A$3.48 B6.38%
2006-12-31A$3.27 B5.86%
2005-12-31A$3.09 B19.52%
2004-12-31A$2.58 B23.78%
2003-12-31A$2.09 B-5.95%
2002-12-31A$2.22 B-11.38%
2001-12-31A$2.51 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$195.15 B 177.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$100.69 B 43.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$119.08 B 69.47%๐Ÿ‡บ๐Ÿ‡ธ USA
A$89.33 B 27.13%๐Ÿ‡ซ๐Ÿ‡ท France